Clinical Trial Update: EMD 525797 in Colorectal and Ovarian Cancer Patients With Liver Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on EMD 525797 for colorectal and ovarian cancer patients with liver metastases; study status is completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Ovarian Cancer

Drugs mentioned

• EMD 525797

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Colorectal and Ovarian Cancer Patients With Liver Metastases | Phase 1 | Status: COMPLETED | Results posted: 2015-12-14